ライフサイエンスコーパス: mean blood pressure

1 ke, independent of direction of variation or mean blood pressure.

2 nosis and treatment focus only on underlying mean blood pressure.

3 risk of stroke and expected effects based on mean blood pressure.

4 SD) and as transformations uncorrelated with mean blood pressure.

5 -stimulus period and significantly increased mean blood pressure.

6 input, thus contributing to the increase in mean blood pressure.

7 The primary outcome was the change in 24-h mean blood pressure.

8 height correlated with all variables except mean blood pressure.

9 fort of the left ventricle, even at the same mean blood pressures.

10 onset of stretch) by a transient increase in mean blood pressure (101.9 +/- 0.3%, P < 0.05) from the

11 usion alone had a small effect of increasing mean blood pressure (12 +/- 3 mm Hg), which in itself di

12 D) age of the patients was 64+/-8 years, the mean blood pressure 133+/-17/78+/-10 mm Hg, and the mean

13 56 patients, mean blood pressure 161/98 mm Hg, entered the rotation,

14 All patients were hypertensive (mean blood pressure: 194/103 mmHg; mean medications: 2.4

15 group achieved a greater decrease in 24-hour mean blood pressure (3.1 mm Hg [95% CI, 0.6 to 5.6]; P =

16 plus laparotomy) or T-H (midline laparotomy, mean blood pressure 35 +/- 5 mmHg for 90 min, followed b

17 (midline laparotomy) and hemorrhagic shock (mean blood pressure 35-40 mm Hg for 90 minutes) followed

18 ximately 300 g) underwent trauma-hemorrhage (mean blood pressure, 40 mm Hg for 90 min, then resuscita

19 We analysed the associations between mean blood pressure achieved on treatment; prerandomisat

20 primary end point was the change in 24-hour mean blood pressure after 12 weeks.

21 during BAO not only prevented the increased mean blood pressure after forced exercise, but also sign

22 Mean blood pressures after dose adjustment were 131.6/73

23 of stroke more than expected on the basis of mean blood pressure alone and that beta blockers are les

24 we plotted the following on a monthly basis: mean blood pressure among hypertensive patients, mean fa

25 Study-2: mean blood pressure and carotid intima-media thickness w

26 The magnitude of spontaneous changes in mean blood pressure and CBF velocity were quantified by

27 re, adjusting for age, sex, body mass index, mean blood pressure and comorbidity (i.e. hypertension,

28 ury (high bilirubin), circulatory shock (low mean blood pressure and elevated serum lactate); Profile

29 Mean blood pressure and growth curves were fitted for fe

30 was no difference in the 24-hour rhythms of mean blood pressure and heart rate between the two group

31 muscle sympathetic nerve activity responses, mean blood pressure and heart rate were higher during mo

32 In this cohort study, higher mean blood pressure and higher SD of blood pressure were

33 The interaction terms of higher mean blood pressure and higher SD of blood pressure were

34 ated coffee, and total caffeine intakes with mean blood pressure and incident hypertension in postmen

35 treated for hypertension, only ET decreased mean blood pressure and MSNA and improved sympathetic BR

36 triplets and quadruplet (four or more)] and mean blood pressure and R-R interval were tracked for 15

37 The peptides had no effect on mean blood pressure and significantly reduced parasitemi

38 Mean blood pressure and the prevalence of raised blood p

39 sociated with higher systolic, diastolic and mean blood pressures and peak LV systolic pressure, comp

40 ciation of OAG with systolic, diastolic, and mean blood pressures and perfusion pressures.

41 deviation [SD] and parameters independent of mean blood pressure) and maximum blood pressure in patie

42 e adjusted for age, body mass index, height, mean blood pressure, and CV risk factors.

43 in, hemoglobin A1c levels, serum creatinine, mean blood pressure, and mean number of antihypertensive

44 Rats underwent trauma-hemorrhage (mean blood pressure approximately 40 mm Hg for 90 mins)

45 tes (interquartile range, 41 to 93), and the mean blood pressure at randomization was 178/98 mm Hg.

46 The mean blood pressure before ablation was 149/90 mm Hg wit

47 L-DOPS significantly raised mean blood pressure both supine (from 101+/-4 to 141+/-5

48 use of antihypertensive medications, global mean blood pressure (BP) has remained constant or has de

49 in response to proportionate (%) changes in mean blood pressure (BP) induced by stepwise sodium nitr

50 Mean blood pressure (BP) was computed using up to 3 meas

51 h the vehicle control, ITE elevated maternal mean blood pressure by 22% and 16% on GD16 and 17, respe

52 eprocedure and postprocedure heart rates and mean blood pressures compared with patients who were not

53 Mean blood pressure declined from 146/86 mmHg to 134/72

54 Mean blood pressure decreased significantly after ET but

55 The mean blood pressure decreased to 134/77 mm Hg 1 month af

56 Mean blood pressure dropped from 151.7/86.4 to 138.4/80.

57 Heart rate and mean blood pressure during echo and catheterization were

58 egression analyses of the mean SR versus the mean blood pressure effect adjusted for effect modifiers

59 Overall mean blood pressure fell from 173/99 mm Hg (SD 14/8) to

60 Mean blood pressure from both techniques may be interpre

61 After 12 months, the mean blood pressure had decreased to 128.2/73.8 mm Hg in

62 planted 1 week before starting the diet, and mean blood pressure, heart rate, and motor activity were

63 dex, mean arterial blood pressure, change in mean blood pressure, heart rate, change in heart rate, t

64 gnificant changes in systolic, diastolic, or mean blood pressure, heart rate, or IOP during all four

65 ssociated with age, sex, height, heart rate, mean blood pressure, hemoglobin level, country, and hemo

66 Mean blood pressure increased by 10 +/- 1 mm Hg, and hea

67 Mean blood pressure levels and rates of awareness, treat

68 We used global data on mean blood pressure levels and sodium and trans fat inta

69 257) and compared differences in accumulated mean blood pressure levels at sequential times in the tr

70 blood pressure-lowering treatment group had mean blood pressure levels of 133/76 mm Hg, compared wit

71 The mean blood pressure levels of men and women in the gener

72 ssure by 10%-20% within the first 24 h and a mean blood pressure <140/90 mm Hg within seven days) or

73 ceive treatment on day 8 (aimed at achieving mean blood pressure <140/90 mm Hg).

74 Systemic mean blood pressure (MAP) was monitored through a cathet

75 s produced earlier and greater reductions in mean blood pressure (MBP) and increased, rather than dec

76 Hypotension is common in septic children, mean blood pressure (MBP) guides vasoactive agent titrat

77 Comparative effects on heart rate (HR) and mean blood pressure (MBP) were also studied.

78 e (sBP), diastolic blood pressure (dBP), and mean blood pressure (mBP) were assessed in response to A

79 Heart rate and mean blood pressure (mBP) were monitored throughout the

80 Kir2.1(+/-) mice also show increased mean blood pressure measured by carotid artery cannulati

81 The mean blood pressure, minimum lumen diameter (MLD), numbe

82 e treatment group had a significantly higher mean blood pressure (mm Hg) (110+/-6 group 3; 86+/-7 gro

83 on was discontinued in cases of decreases in mean blood pressure of > or =20% or intolerable itching.

84 cebo (moderate blood pressure control) had a mean blood pressure of 137+/-0.7/81+/-0.3 mm Hg over the

85 Unheparinized male rats were bled to a mean blood pressure of 45 +/- 3 mmHg.

86 Animals were bled to a mean blood pressure of 45 mmHg (1 mmHg = 133 Pa) and res

87 The mean blood pressure of all animals was above 65 mm Hg, i

88 The mean blood pressure of the participants at baseline was

89 There was a diurnal-to-nocturnal decrease in mean blood pressure only in the glaucoma group.

90 e in heart rate but no significant change in mean blood pressure or vascular resistance.

91 Draft eligibility reduced mean blood pressure outcomes (e.g., effect on SBP: -1.33

92 del or over its components including age and mean blood pressure (p < 0.05 for all).

93 r activity decreased heart rate (P < 0.001), mean blood pressure (P = 0.009) and minute ventilation (

94 potential covariates that were analyzed were mean blood pressure, patient acuity using the Simplified

95 Rectal and cranial temperatures, mean blood pressure, plasma glucose and blood gases were

96 ars were evaluated (systolic, diastolic, and mean blood pressure; plasma lipids; high-sensitivity C-r

97 The change in mean blood pressure produced by HM administration as a f

98 ours of CPAP use and the decrease in 24-hour mean blood pressure (r = 0.29, P = .006), SBP (r = 0.25;

99 se in rcSO2 was negatively correlated to the mean blood pressure (r = 0.60, p < 0.0001).

100 creased Akt activity in the brain, decreased mean blood pressure, reduced cerebral infarct volume, an

101 h AV than with ventricular pacing (change in mean blood pressure +/- SE: 10 +/- 3 vs. 2 +/- 2 mm Hg a

102 chniques in the ICU and whether systolic vs. mean blood pressures should be targeted in therapeutic p

103 Each subject's mean blood pressure, the slope of the regression of his

104 Mean blood pressure, total cholesterol, LDL-cholesterol,

105 vice specialty, body mass index, waist size, mean blood pressure, unhealthy behaviors, lipid profiles

106 our patients had elevated blood pressure but mean blood pressure values were not statistically differ

107 The primary outcome was mean blood pressure variability before versus after the

108 fusion of phenylephrine and normalization of mean blood pressure variability by oscillatory lower bod

109 very low frequency range (0.02 to 0.07 Hz), mean blood pressure variability decreased significantly

110 Baseline 24-hour mean blood pressure was 103.4 mm Hg; systolic blood pres

111 18 years (IQR 12-28), 99 (52%) were female, mean blood pressure was 110/65 mm Hg (SDs 16 and 12), an

112 Mean blood pressure was 129 (15)/76 (10) mm Hg, with hyp

113 During the trial phase, the mean blood pressure was 130/78 mm Hg in the intensive-co

114 The mean blood pressure was 138 +/- 19/79 +/- 11 mm Hg, rend

115 min/1.73 m(2), the mean RAS was 76%, and the mean blood pressure was 150/76 mm Hg; 83% of the revascu

116 At baseline, the mean blood pressure was 151/88 and 151/83 mm Hg for the

117 ate was 85 (SD 19) mL/min per 1.73 m(2), and mean blood pressure was 175/98 (SD 16/14) mm Hg.

118 Their mean blood pressure was greater despite more intensive a

119 Mean blood pressure was higher in SHR versus WKY (P<0.01

120 main contributor to systolic, diastolic and mean blood pressure was level of PMN elastase.

121 Maternal mean blood pressure was measured on GD16-20.

122 A significant treatment effect on mean blood pressure was observed (-9.0 mm Hg; 95% confid

123 The mean blood pressure was significantly reduced after dial

124 The longitudinal change in mean blood pressure was similar in donors and nondonors.

125 Mean blood pressure was similar in rats with 2K-1C hyper

126 Heart rate and mean blood pressure were monitored in all animals.

127 Heart rate and mean blood pressure were monitored.

128 During the cohort phase, corresponding mean blood pressures were 131/78 mm Hg and 134/78 mm Hg.

129 ing in both systole and diastole, as well as mean blood pressure, were more compromised in rats bred

130 blood-pressure-lowering drugs should reduce mean blood pressure without increasing variability; idea